দেশ: নিউ জিলণ্ড
ভাষা: ইংরেজি
সূত্র: Medsafe (Medicines Safety Authority)
Sumatriptan succinate 16.8 mg/mL;
GlaxoSmithKline NZ Limited
Sumatriptan succinate 16.8 mg/mL
6 mg/0.5mL
Solution for injection
Active: Sumatriptan succinate 16.8 mg/mL
Syringe, 0.5ml sample pack, 2 dose units
Prescription
Prescription
Divi's Laboratories Limited
IMIGRAN Injection is indicated for the acute relief of migraine attacks with or without aura, and for the acute treatment of cluster headache.
Package - Contents - Shelf Life: Syringe, 0.5ml sample pack - 2 dose units - 24 months from date of manufacture stored at or below 30°C - Syringe, 0.5ml refill pack - 2 dose units - 24 months from date of manufacture stored at or below 30°C
1991-04-11
1 IMIGRAN INJECTION SUMATRIPTAN SUCCINATE INJECTION 6 MG/0.5 ML Consumer Medicine Information WHAT IS IN THIS LEAFLET? Please read this leaflet carefully before you start using IMIGRAN_ _injection. This leaflet answers some common questions about IMIGRAN_ _injection. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking IMIGRAN_ _injection against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT IMIGRAN_ _ INJECTION IS USED FOR IMIGRAN_ _injection contains the active ingredient sumatriptan succinate. This medicine belongs to a group of drugs called serotonin agonists. IMIGRAN_ _injection is used to relieve headache and other symptoms of a migraine attack. It should not be used to prevent migraine attacks from occurring. IMIGRAN_ _injection may be used for migraine headaches with or without what is known as 'aura'. There is no information on the use of IMIGRAN_ _injection in special kinds of migraine known as 'basilar migraine', ‘ophthalmoplegic migraine’ or 'hemiplegic migraine'. It is thought that migraine headache is due to widening of certain blood vessels in the head. IMIGRAN_ _injection works by making those vessels normal again and easing the symptoms of migraine. IMIGRAN injection is also used for treatment of cluster headache. BEFORE YOU USE YOUR IMIGRAN INJECTION _WHEN YOU MUST NOT USE _ _IT _ Do not use IMIGRAN_ _ injection if you have ever had an allergic reaction to sumatriptan succinate or any of the ingredients listed at the end of this leaflet. Symptoms of an allergic reaction may be mild or severe. They usually include some or all of the following: wheezing, swelling of the lips/mouth, difficulty in breathing, hayfever, lumpy rash ("hives") or fainting. Do not take IMIGRAN সম্পূর্ণ নথি পড়ুন
1 NEW ZEALAND DATA SHEET 1. PRODUCT NAME IMIGRAN injection 6 mg/0.5 mL solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each pre-filled syringe contains 6 mg of sumatriptan base, as the succinate salt, in 0.5 mL. For the full list of excipients, see section 6.1 List of excipients. 3. PHARMACEUTICAL FORM Subcutaneous solution for injection. Pre-filled syringe containing a colourless to pale yellow, isotonic solution. The pre-filled syringe can only be used in conjunction with an autoinjector. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS IMIGRAN injection is indicated for the acute relief of migraine attacks with or without aura, and for the acute treatment of cluster headache in adults aged 18 years and over. 4.2 DOSE AND METHOD OF ADMINISTRATION Dose IMIGRAN injection should not be used prophylactically. The recommended dose of sumatriptan should not be exceeded. It is recommended to start the treatment at the first sign of a migraine headache or associated symptoms such as nausea, vomiting or photophobia. The efficacy of sumatriptan is independent of the duration of the attack when starting treatment. Administration during a migraine aura prior to other symptoms occurring may not prevent the development of a headache. ADULTS (18 YEARS AND OVER) Migraine _ _ The recommended adult dose of IMIGRAN injection is a 6 mg subcutaneous injection. If a patient does not respond to the first dose of IMIGRAN, a second dose should not be taken for the same attack. IMIGRAN injection may be taken for subsequent attacks. If the patient has responded to the first dose, but the symptoms recur a second dose may be given in the next 24 hours, provided that there is a minimum interval of one hour between the two doses. 2 The maximum dose in 24 hours is two 6 mg injections (12 mg). _Cluster Headache_ The recommended adult dose of IMIGRAN injection is a single 6 mg subcutaneous injection for each cluster attack. The maximum dose in 24 hours is two 6 mg injections (12 mg) with a minimum interval of one hour betw সম্পূর্ণ নথি পড়ুন